Register
|
Login
Published News
Upcoming News
Submit a New Story
Blogs
Clinical Trials
Conferences & Events
Corporate
Financial
Product
Publications
Research & Development
RSS
2
Vote
Drug Injury Watch: FDA Alerts Doctors That Revlimid Can Cause Serious Skin Reactions In Patients
Posted by
tjlpa
702 days ago (
http://www.drug-injury.com
)
Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, And Erythema Multiforme Are Associated With Revlimid Use
Who Voted for this Story
worldpharmanews
tjlpa
Related Links
Drug Injury Watch: April 2008: FDA Web Site Adds Two New Pages For Learning About Drug Safety
Drug Injury Watch: FDA's 2007 Report On Outstanding Post-approval Studies: No Progress Made By Big Pharma
Drug Injury Watch: FDA Says It Doesn't Know How Long Defective Digitek / Digoxin Pills Were Sold
Drug Injury Watch: Extent Of Digitek Recall Remains A Mystery Ten Days Later; Patients Are Left In The Dark
Drug Injury Watch: Recall Notice For Digitek Marketed Under Bertek Label Goes Back To March 2006
Drug Injury Watch: FDA Safety Evaluation Of Antibiotic Maxipime Is Not Completed, Yet
Drug Injury Watch: Actavis Tells Us More, But Not Much More, About Extent Of Digitek Recall
Drug Injury Watch: Do Enbrel, Humira, Or Remicade Cause Cancer In Children And Young Adults?
Drug Injury Watch: Another "Double-Dose" Pill Problem Demonstrates How And Why The Digitek Recall Is So Unusual
Drug Injury Watch: FDA Staff Wants Amgen To Add Stronger Warning About Enbrel Side Effects In Children
Comments
Log in to comment
or register
here
.
Subscribe
Enter your email address:
Delivered by
FeedBurner
Top Users
Tag cloud
Live
Comments